XML 36 R24.htm IDEA: XBRL DOCUMENT
v3.21.2

Stock Compensation Plans (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2021
Share-based Payment Arrangement [Abstract] |
Schedule of stock inventive plan changes |
Schedule of stock inventive plan changes |  |  |  |  |  |  |  |
|  | Number of Class A Shares |  | Weighted Average Exercise Price |  | Number of Class C Shares |  | Weighted Average Exercise Price
Outstanding at January 1, 2021 |  |  | 1,072,863 |  |  | $ | 4.22 |  |  |  | 662,666 |  |  | $ | 4.61 |
Adjustment for effect of stock dividends |  |  | 47,594 |  |  |  |  |  |  |  | 33,136 |  |  |  |  |
Granted |  |  | — |  |  |  |  |  |  |  | — |  |  |  |  |
Exercised |  |  | (97,313 | ) |  |  |  |  |  |  | — |  |  |  |  |
Cancelled |  |  | — |  |  |  |  |  |  |  | — |  |  |  |  |
Outstanding at June 30, 2021 |  |  | 1,023,144 |  |  | $ | 4.29 |  |  |  | 695,802 |  |  | $ | 4.61 |
As of June 30, 2021: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options exercisable |  |  | 1,023,144 |  |  | $ | 4.29 |  |  |  | 695,802 |  |  | $ | 4.61 |
As of June 30, 2021: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Available options for future grant |  |  | 358,462 |  |  |  |  |  |  |  | 279,825 |  |  |  |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
outstanding at June 30, 2021 |  |  | 5.18 years |  |  |  |  |  |  |  | 6.32 years |  |  |  |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
exercisable at June 30, 2021 |  |  | 5.18 years |  |  |  |  |  |  |  | 6.32 years |  |  |  |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
outstanding at June 30, 2021 (1) |  | $ | 4,135,399 |  |  |  |  |  |  | $ | 2,585,420 |  |  |  |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
exercisable at June 30, 2021 (1) |  | $ | 4,135,399 |  |  |  |  |  |  | $ | 2,585,420 |  |  |  |  |
(1) | The Company used a stock price of $8.33 as of June 30, 2021 to derive intrinsic value.
A summary of the status of the Company’s stock compensation plans as of June 30, 2020, and the changes during the six months ended June 30, 2020, are presented below:
|  | Number of Class A Shares |  | Weighted Average Exercise Price |  | Number of Class C Shares |  | Weighted Average Exercise Price
Outstanding at January 1, 2020 |  |  | 1,086,053 |  |  | $ | 4.41 |  |  |  | 594,132 |  |  | $ | 5.36 |
Adjustment for effect of stock dividends |  |  | 29,099 |  |  |  |  |  |  |  | 22,544 |  |  |  |  |
Granted |  |  | 77,000 |  |  |  |  |  |  |  | 180,000 |  |  |  |  |
Exercised |  |  | (78,803 | ) |  |  |  |  |  |  | — |  |  |  |  |
Cancelled |  |  | — |  |  |  |  |  |  |  | — |  |  |  |  |
Outstanding at June 30, 2020 |  |  | 1,113,349 |  |  | $ | 4.27 |  |  |  | 796,676 |  |  | $ | 4.87 |
As of June 30, 2020: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Options exercisable |  |  | 1,013,955 |  |  | $ | 4.27 |  |  |  | 561,440 |  |  | $ | 5.11 |
As of June 30, 2020: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Available options for future grant |  |  | 325,372 |  |  |  |  |  |  |  | 266,500 |  |  |  |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
outstanding at June 30, 2020 |  |  | 5.97 years |  |  |  |  |  |  |  | 6.18 years |  |  |  |  |
Weighted average contractual term of options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
exercisable at June 30, 2020 |  |  | 5.61 years |  |  |  |  |  |  |  | 5.32 years |  |  |  |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
outstanding at June 30, 2020 (1) |  | $ | 2,568,502 |  |  |  |  |  |  | $ | 1,360,855 |  |  |  |  |
Aggregated intrinsic value of options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
exercisable at June 30, 2020 (1) |  | $ | 2,338,090 |  |  |  |  |  |  | $ | 823,712 |  |  |  |  |
(1) | The Company used a stock price of $6.58 as of June 30, 2020 to derive intrinsic value.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration